Zai Lab (ZLAB) Change in Cash (2018 - 2026)
Zai Lab (ZLAB) posted Change in Cash of -$28.3 million for Q1 2026, up 24.81% sequentially from -$37.6 million in Q4 2025, and down 109.19% YoY from $307.6 million in Q1 2025.
Analysis
Zai Lab (ZLAB) Change in Cash (2018 - 2026) Analysis & Trends
Zai Lab has reported Change in Cash for 9 years, with the latest figure at -$28.3 million in Q1 2026.
- Quarterly Change in Cash fell 109.19% year-over-year to -$28.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$105.9 million (down 199.49% YoY) and the FY2025 annual result came in at $229.9 million, up 195.6% from the prior year.
- Change in Cash rose to -$28.3 million in Q1 2026 per ZLAB's latest filing, from -$37.6 million in the prior quarter.
- Over five years, Change in Cash peaked at $438.7 million in Q3 2022 and troughed at -$166.4 million in Q4 2024.
- A 5-year average of -$12.5 million and a median of -$28.3 million in 2026 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2024 and 2025: Change in Cash slumped 25088.44% in 2024, then jumped 881.29% in 2025.
- Over 5 years, Change in Cash stood at -$111.0 million in 2022, then jumped by 100.6% to $666000.0 in 2023, then plunged by 25088.44% to -$166.4 million in 2024, then jumped by 77.42% to -$37.6 million in 2025, then increased by 24.81% to -$28.3 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$28.3 million, -$37.6 million, and -$15.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -185.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 427.25 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.94 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Zai Lab | 2.94 Bn | 2.23 Bn | 58.15 Mn | -43.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -43.79 Mn |
| Mar 31, 2026 | -28.26 Mn |
| Dec 31, 2025 | -37.58 Mn |
| Sep 30, 2025 | -15.11 Mn |
| Jun 30, 2025 | -24.99 Mn |
| Mar 31, 2025 | 307.60 Mn |
| Dec 31, 2024 | -166.42 Mn |
| Sep 30, 2024 | -13.96 Mn |
| Jun 30, 2024 | -20.73 Mn |
| Mar 31, 2024 | -39.37 Mn |
| Dec 31, 2023 | 666,000.00 |
| Sep 30, 2023 | -70.35 Mn |
| Jun 30, 2023 | -19.90 Mn |
| Mar 31, 2023 | -128.43 Mn |
| Dec 31, 2022 | -111.01 Mn |
| Sep 30, 2022 | 438.66 Mn |
| Jun 30, 2022 | -166.14 Mn |
| Mar 31, 2022 | -117.14 Mn |
| Dec 31, 2021 | -434.34 Mn |
| Sep 30, 2021 | -368.08 Mn |